Reasons to bring NGS to your lab
Bring NGS capabilities to your lab today
Take advantage of decreasing costs and broader research capabilities
Expand your scale and discovery power
Researchers are shifting to NGS to expand the scale and discovery power of their genomics studies. With the simplicity of benchtop sequencing systems, NGS equipment is now accessible to laboratories of all sizes. Due to this accessibility, many researchers are choosing to bring NGS into their labs. Owning an NGS system is seen as an investment in high-quality, reproducible data that leads to valuable biological insights.
If you’re just starting out or have limited resources, outsourcing your experiments to core labs can be a good way to get started with NGS. They offer end-to-end support and collaborate on your experimental design to ensure success.
With decades of experience, Illumina is dedicated to increasing access and simplifying workflows and analysis, allowing for easy, quick adoption of NGS in your own lab.
Reasons to bring NGS into your lab
Having an NGS system in your lab gives you tight control over your NGS projects and samples for lab efficiency and time savings. By controlling your own samples, you also control your own data and workflows. And with an ecosystem of user-friendly solutions, comprehensive expert support, and proven performance, becoming an NGS expert is easy with Illumina.
Fast turnaround times
In-lab benchtop sequencing allows you to control your samples and data, improve turnaround times, and utilize the power of NGS to complete your experiments faster.
Cost-effective
Decreasing sequencing costs make NGS more cost-efficient than ever. It can identify variants and expression patterns across thousands of target regions, down to single-base resolution, in a single experiment, making it much more cost-efficient and scalable than conventional, less comprehensive methods.1-5
Simple workflows
With user-friendly, scalable onboard software solutions from Illumina, analysis is easier than ever. Our integrated software portfolio features secure, versatile solutions with award-winning accuracy, connecting data across the wet and dry lab.
Control your samples and data
You will enhance your genomic data privacy with tighter control over your NGS samples and projects, leading to high-quality, reproducible data.
Expand the utility of NGS, accelerating your research
Its massive-scale, combinatorial reading and counting capabilities will enable you to expand the scope and impact of your research by starting with a broader view.
Start sequencing in your lab
NGS expands the scope and depth of your studies, enabling higher discovery power for a wide array of published applications and methods for diverse sample types. Benchtop sequencers are ideal for NGS users looking to bring NGS to their labs for the first time, due to their simplicity and accessibility.
Here are some suggested sequencers that may a good fit for 1st-time users:
MiSeq System
The MiSeq System has a simplified NGS workflow that makes it easy for novice users to access NGS, quickly and reliably. With more than 10,000 systems shipped globally, the MiSeq System has the largest benchtop system install base on the market. Cited in over 100,000 peer-reviewed publications6, it has been trusted for over a decade.
NextSeq 1000 & 2000 Systems
The NextSeq 1000 and NextSeq 2000 Sequencing Systems are flexible and scalable, empowering scientists to explore applications like single-cell, whole-exome, and RNA sequencing. With more than 2000 systems shipped globally, they feature simplified run setup, minimal touchpoints, and flexible informatics solutions, including onboard DRAGEN software.
Why choose Illumina?
Illumina is the proven leader in sequencing, with the largest sequencing ecosystem with a broad range of products, from sample preparation to analysis. With global infrastructure and support, we’re here to support every step of the way.
When you partner with Illumina, you’ll get more than just leading-edge technology–you become part of a community with like-minded goals and results, contributing to Illumina being cited more than any other sequencing company.
369,000+ sequencing publications
9000+ customers served
20,000+ instrument installed
3000+ trainings per year
15+ Illumina Solution Centers
600+ support personnel
150+ countries served
> 1B in R&D investment
Illumina product support
Get comprehensive support
- Global support including remote technical support 24/5, onsite training, instrument qualification and onboarding solutions
- 96% customer satisfaction
- 97% of calls answered in <30 seconds
- < 1 day mean time to repair
- 2-day average FSE response time
Connect with fellow innovators
Become a part of a community advancing science together by leading the latest advancements in research and sharing best practices.
Explore illumina partners
Illumina partnerships are expanding access to NGS, pioneering new applications and technologies, providing funding for innovative startups, and more.
NGS buyer’s guide
This comprehensive guide will walk you through the entire decision process by helping you evaluate your research goals and laboratory needs.
- Key questions to ask before purchasing your NGS system
- Key considerations for sequencing and data analysis platforms
- NGS buyer’s checklist
Additional resources
NGS cost considerations
The cost of NGS has rapidly decreased, making it more accessible than ever. These cost considerations and resources will help with your budget planning.
Financial solutions
Illumina Financial Services offers fast, easy, and affordable financing and leasing programs. With our Illumina-backed solutions and leasing partner network, we can offer options that fit your needs.
Tutorials & online training
Browse our comprehensive list of tutorials designed to help you understand key concepts in NGS. We’ll guide you through best practices for library prep, sequencing, and data analysis.
Want to discuss benchtop sequencing options?
Speak to sales today about choosing the right benchtop sequencer based on your needs.
References
- Jamuar SS, Lam at, Kircher M, et al. Somatic mutations in cerebral cortical malformations. N Engl J Med. 2014;371(8):733743. doi:10.1056/NEJMoa1314432
- Rivas Ma, Beaudoin M, Gardet a, et al. Deep resequencing of GWaS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet. 2011;43(11):1066-1073. doi:10.1038/ng.952
- König K, Peifer M, Fassunke J, et al. Implementation of amplicon Parallel Sequencing Leads to Improvement of Diagnosis and therapy of Lung Cancer Patients. J Thorac Oncol. 2015;10(7):1049-1057. doi:10.1097/JtO.0000000000000570
- Shendure J, Ji h. Next-generation DNA sequencing. Nat Biotechnol. 2008;26(10):1135-1145. doi:10.1038/nbt1486 Schuster SC. Next-generation sequencing transforms today's biology. Nat Methods. 2008;5(1):16-18. doi:10.1038/nmeth1156
- Data calculations on file, Illumina, Inc. 2023.